Pfizer's Sutent wins US FDA's OK in rare pancreatic cancer
23 May 2011
Donna Young
Please Login to read the full article.
23 May 2011
Donna Young
donna.young@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- US FDA grants OK to Novartis' Afinitor in rare kidney tumours
- US FDA reviewers question benefits of Merck/Ariad, GSK sarcoma drugs
- With questions raised on prostate cancer benefit, Amgen's Xgeva may face tough ODAC
- FDA reviewers question efficacy of Pfizer's kidney cancer drug ahead of ODAC
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
